v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Commercialization revenue $ 7,886 $ 0
License and collaboration revenue 687 63,573
Revenue from Contract with Customer, Including Assessed Tax, Total 8,573 63,573
Costs and operating expenses:    
Cost of commercialization revenue 8,886 0
Research and development expenses 224,785 272,533
General and administrative expenses 50,908 71,553
Total costs and operating expenses 284,579 344,086
Loss from operations (276,006) (280,513)
Other income (expense), net:    
Interest income 5,426 3,059
Interest expense (5,285) (373)
Gain on sale of ATOM Facility (See Note 7) 0 50,237
Other income (expense), net: (246) (700)
Total other income (expense), net (105) 52,223
Loss before provision for income taxes (276,111) (228,290)
Provision for income taxes 15 12
Net loss (276,126) (228,302)
Other comprehensive gain (loss):    
Unrealized gain (loss) on available-for-sale securities 1,863 (1,699)
Comprehensive loss $ (274,263) $ (230,001)
Net loss per common share:    
Basic net loss per common share $ (2.61) $ (2.24)
Diluted net loss per common share $ (2.61) $ (2.24)
Basic weighted-average shares outstanding 105,912 101,990
Diluted weighted-average shares outstanding 105,912 101,990

Source

10-K
HTML PDF
XBRL
ZIP